Recent Blog Articles
Talking to your doctor about your LGBTQ+ sex life
Untangling grief: Living beyond a great loss
Thunderstorm asthma: Bad weather, allergies, and asthma attacks
Heart problems and the heat: What to know and do
I’m too young to have Alzheimer’s disease or dementia, right?
Period equity: What it is and why it matters
Back pain: Will treatment for the mind, body—or both—help?
Colon cancer screening decisions: What’s the best option and when?
Cognitive effects in midlife of long-term cannabis use
If climate change keeps you up at night, here's how to cope
Omega-3 fatty acids and the heart: New evidence, more questions
- By Alyson Kelley-Hedgepeth, MD, Contributor
About the Author
Alyson Kelley-Hedgepeth, MD, Contributor
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
There are two possible reasons that STRENGTH provided negative results from omega 3 supplementation: (1) The DHA component of the combined (EPA/DHA) combination negated the benefits of EPA and/or (2) The levels of EPA achieved were insufficient and (sub par ) compared to prior trials eg JELIS and REDUCE-IT to achieve the CV benefits desired. The discussion regarding the corn oil placebo in STRENGTH and the mineral oil placebo in REDUCE-IT is an un-substantiated distractor. Further , the risks of atrial fibrillation are overblown and entirely dependent on the clinical risk substrate. The investigators in STRENGTH overcall the risks of omega 3 induced Atrial Fibrillation and overplay the failure of “all” omega 3’s. We await after JELIS and REDUCE-IT a third large trial to confirm what seems well established that pure EPA omega 3 in the right dose in addition to statin is a very powerful adjunct in the armamentarium for primary or secondary cardiovascular event prevention with NNT’s in the 15-25 range which is spectacular!
Do your patients report any unexpected benefits from taking Vascepa, maybe due to its anti-inflammatory nature? Obviously, the greatly reduced risk of heart attack/stroke/death is the primary benefit, just wondering about other positive effects it may have.
Commenting has been closed for this post.
You might also be interested in…
Harvard Heart Letter
Be on your way to a healthy heart. Subscribe to Harvard Heart Letter today. Each month, you’ll get easy-to-try nutrition and exercise advice that will improve your heart’s health and overall well-being. In Harvard Heart Letter, you’ll also read about today’s breakthrough medications and treatments as well as advice from Harvard’s doctors on side effects, drug interactions, and surgery precautions.
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!